SCHEMBL5639474

SCHEMBL5639474

COCCSCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9640732 0.87 MVD (0.47)
SCHEMBL10044363 0.86 GMNN (0.55)
SCHEMBL2474100 0.81
SCHEMBL17418515 0.79 LMNA (0.64)
Hydrochloric Acid SCHEMBL9696329 0.79 MVD (0.35)
SCHEMBL5638161 0.79 TSHR (0.40)
SCHEMBL8048722 0.77 MAPT (0.50)
SCHEMBL1313188 0.76 CYP2D6 (0.73)
SCHEMBL10317271 0.76 MVD (0.44)
SCHEMBL8727713 0.76 CYP2D6 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120184613-A1 SULFUR-CONTAINING COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-07-19 US disclosed
WO-2011044505-A2 ENZYME INHIBITING COMPOUNDS AND METHODS BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2011-04-14 WO disclosed
US-20090042191-A1 SYSTEM AND METHOD FOR SECURE DOCUMENT PRINTING AND DETECTION APDN (B.V.I.) INC. 2009-02-12 US disclosed
US-20090042191-A1 SYSTEM AND METHOD FOR SECURE DOCUMENT PRINTING AND DETECTION APDN (B.V.I.) INC. 2009-02-12 US disclosed
US-7229987-B2 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes ELI LILLY AND COMPANY (US) 2007-06-12 US disclosed
US-7229987-B2 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes ELI LILLY AND COMPANY (US) 2007-06-12 US disclosed
US-7229987-B2 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes ELI LILLY AND COMPANY (US) 2007-06-12 US disclosed
US-20050272718-A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes AMMENN ET AL, JOCHEN 2005-12-08 US disclosed
EP-1505968-A1 MULTICYCLIC COMPOUNDS FOR USE AS MELANIN CONCENTRATING HORMONE ANTAGONISTS IN THE TREATMENT OF OBESITY AND DIABETES ELI LILLY AND COMPANY (US) 2005-02-16 EP disclosed
WO-2003097047-A1 MULTICYCLIC COMPOUNDS FOR USE AS MELANIN CONCENTRATING HORMONE ANTAGONISTS IN THE TREATMENT OF OBESITY AND DIABETES ELI LILLY AND COMPANY (US) 2003-11-27 WO disclosed
EP-0131374-B1 PROCESS AND INTERMEDIATES FOR THE PREPARATION OF PENEM DERIVATIVES PFIZER INC. (US) 1988-11-23 EP disclosed
US-4725678-A ANTIBIOTICS PFIZER INC. (US) 1988-02-16 US disclosed
US-4595539-A Containing acid or ester groups and sulfur PFIZER INC. (US) 1986-06-17 US disclosed
EP-0131374-A1 Process and intermediates for the preparation of penem derivatives PFIZER INC. (US) 1985-01-16 EP disclosed
EP-0128725-A1 Preparation of penem derivatives PFIZER INC. (US) 1984-12-19 EP disclosed
US-4279806-A Antimony mercaptides as processing stabilizers for vinyl halide resins ASSOCIATED LEAD INC. (US) 1981-07-21 US disclosed